Simplex Trading’s Petros Pharmaceuticals PTPI Stock Holding History

Simplex Trading’s Portfolio PTPI Stock Details PTPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-93	Closed	-$16.9K	–	10686
2022 Q2	$19K	Buy	93 +53	+133%	+$13.3K	﹤0.01%	7678
2022 Q1	$15K	Buy	+40	New	+$16.9K	﹤0.01%	8543

Other funds holding PTPI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Simplex Trading's PTPI Position: Q3 2022 in Review

Simplex Trading sold out of Petros Pharmaceuticals (PTPI) in Q3 2022, closing a stake of 93 shares — an estimated $16.9K sold.

Simplex Trading first reported a position in PTPI in Q1 2022 and held it in 2 quarters. The position peaked at $19K in Q2 2022. 11 funds tracked by Wall St. Rank hold PTPI as of Q3 2022.

Simplex Trading reported no remaining Petros Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Simplex Trading sold 93 Petros Pharmaceuticals shares in Q3 2022, an estimated $16.9K.
Simplex Trading first reported a position in Petros Pharmaceuticals in Q1 2022 and held it in 2 quarters.
Simplex Trading's Petros Pharmaceuticals position peaked at $19K in Q2 2022.
11 funds tracked by Wall St. Rank held Petros Pharmaceuticals as of Q3 2022.

Based on Simplex Trading's 13F filing for Q3 2022, filed 4 Nov 2022.